Knocke S - Search Results

1

Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells.

Frentzen A, Anggakusuma, Gürlevik E, Hueging K, Knocke S, Ginkel C, Brown RJ, Heim M, Dill MT, Kröger A, Kalinke U, Kaderali L, Kuehnel F, Pietschmann T. Frentzen A, et al. Among authors: knocke s. Hepatology. 2014 Jan;59(1):78-88. doi: 10.1002/hep.26626. Epub 2013 Nov 18. Hepatology. 2014. PMID: 23873628

2

Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses.

Edukulla R, Woller N, Mundt B, Knocke S, Gürlevik E, Saborowski M, Malek N, Manns MP, Wirth T, Kühnel F, Kubicka S. Edukulla R, et al. Among authors: knocke s. Cancer Res. 2009 Feb 15;69(4):1448-58. doi: 10.1158/0008-5472.CAN-08-1160. Epub 2009 Feb 3. Cancer Res. 2009. PMID: 19190348

3

Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses.

Woller N, Gürlevik E, Fleischmann-Mundt B, Schumacher A, Knocke S, Kloos AM, Saborowski M, Geffers R, Manns MP, Wirth TC, Kubicka S, Kühnel F. Woller N, et al. Among authors: knocke s. Mol Ther. 2015 Oct;23(10):1630-40. doi: 10.1038/mt.2015.115. Epub 2015 Jun 26. Mol Ther. 2015. PMID: 26112079 Free PMC article.

4

Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice.

Woller N, Knocke S, Mundt B, Gürlevik E, Strüver N, Kloos A, Boozari B, Schache P, Manns MP, Malek NP, Sparwasser T, Zender L, Wirth TC, Kubicka S, Kühnel F. Woller N, et al. Among authors: knocke s. J Clin Invest. 2011 Jul;121(7):2570-82. doi: 10.1172/JCI45585. Epub 2011 Jun 6. J Clin Invest. 2011. PMID: 21646722 Free PMC article.

5

Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma.

Boozari B, Mundt B, Woller N, Strüver N, Gürlevik E, Schache P, Kloos A, Knocke S, Manns MP, Wirth TC, Kubicka S, Kühnel F. Boozari B, et al. Among authors: knocke s. Gut. 2010 Oct;59(10):1416-26. doi: 10.1136/gut.2009.196519. Epub 2010 Jul 30. Gut. 2010. PMID: 20675696

6

CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations.

Nimanong S, Ostroumov D, Wingerath J, Knocke S, Woller N, Gürlevik E, Falk CS, Manns MP, Kühnel F, Wirth TC. Nimanong S, et al. Among authors: knocke s. Cancer Res. 2017 Apr 15;77(8):1918-1926. doi: 10.1158/0008-5472.CAN-16-2089. Epub 2017 Feb 15. Cancer Res. 2017. PMID: 28202532

7

Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy.

Niemann J, Woller N, Brooks J, Fleischmann-Mundt B, Martin NT, Kloos A, Knocke S, Ernst AM, Manns MP, Kubicka S, Wirth TC, Gerardy-Schahn R, Kühnel F. Niemann J, et al. Among authors: knocke s. Nat Commun. 2019 Jul 19;10(1):3236. doi: 10.1038/s41467-019-11137-5. Nat Commun. 2019. PMID: 31324774 Free PMC article.

8

Tailored Tumor Immunogenicity Reveals Regulation of CD4 and CD8 T Cell Responses against Cancer.

Knocke S, Fleischmann-Mundt B, Saborowski M, Manns MP, Kühnel F, Wirth TC, Woller N. Knocke S, et al. Cell Rep. 2016 Nov 22;17(9):2234-2246. doi: 10.1016/j.celrep.2016.10.086. Cell Rep. 2016. PMID: 27880900 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters